The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)

Phase 4 Completed 821 enrolled Eisai Inc. Pfizer · collab

RandomizedParallel-groupDouble-blindTreatment

Summary

To investigate the efficacy and safety of donepezil in individuals with mild cognitive impairment on measures of cognition, global function and behavior.

Timeline

Start: 2003-12
Primary completion: 2007-03
Completion: 2007-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Donepezil	Small molecule	10 mg	Oral

The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI)

Summary

Timeline

Drugs

Indications